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Abstract 
      The mammalian brain has developed memory systems
mediating rigid, yet evolutionarily adaptive patterns of 
responding to invariant environmental stimuli and internal
demands. Such memory systems promote the recall of 
specific response templates and the execution of 
inflexible actions to liberate buffering capacity for 
performing conscious, explicit cognitive processing. 
The dopamine-innervated neostriatum is central to the 
ability to learn such consistent associations between 
stimuli and actions implicitly. Controlled by their outcome
when initially learned, actions  succumb through iteration
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to the influence of triggering stimuli and progressively detach themselves from 
the pleasurable results originally produced, thereby becoming pervasive 
habits. This might be the case for drug-seeking and drug-taking behaviours, actions 
learned in part through dopamine-dependent drug-induced reinforcement 
when the drug is first experienced. With extended drug use, however, drug-
seeking actions might become conditioned to, and triggered by, specific 
exteroceptive stimuli and/or affective states, gradually becoming irrepressible 
forms of responding. We will review neuroanatomical, neuropharmacological 
and behavioural evidence suggesting that the basal ganglia play a prominent 
role in the shaping of drug addiction, here regarded as a pathological 
modification of otherwise adaptive habit learning systems mediated by the 
basal ganglia. 
 
Introduction 
 The basal ganglia have long been recognised as central to the pathophysiology 
of movement disorders. The early discoveries at the turn of the 20th century 
revealing motor disturbances in patients with damage to the basal ganglia 
[1,2], and many later breakthroughs, were the key in the formation of this 
opinion. Disorders such as Parkinson’s disease –a progressive 
neurodegenerative disorder caused by gradual loss of dopamine input to the 
striatum– and Tourette syndrome –a neurodegenerative condition involving 
reduced caudate volumes in both children and adults– are associated with basal 
ganglia abnormalities. Such pathologies compromise the coherent activity of 
the basal ganglia and allied thalamocortical loop pathways and impair motor 
function as a result. The basal ganglia were first considered as a simple funnel 
system through which cortically born information accessed brainstem motor 
nuclei. This perspective was based on the notion that there was convergence of 
information from distinct cortical areas upon basal ganglia structures, which, in 
turn, resulted in unitary output, composed of mixed functional modalities. 
However, modern theories regard the basal ganglia as a complex multi-channel 
system through which not only motor but also sensory and limbic information 
flows, becomes modified and is subsequently redistributed to the neocortex by 
way of thalamocortical afferents [3,4]. Thus, rather than a funnel, the striatum 
and associated basal ganglia nuclei began to be considered as “a multilaned 
throughway for separate streams of influence...” [5]. The striatum, the main recipient 
of inputs from the cortical mantle, appears to have multiple representations at 
the level of the pallidum and the substantia nigra. The three functional 
modalities (sensorimotor, associative and limbic) of the striatum are processed 
through segregated channels maintaining the specific topography of the 
corticostriate projection. This basic organisational scheme seems to apply to 
the various re-entrant, parallel circuits linking cortex, basal ganglia and 
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thalamus [4,6,7]. Such novel conceptualization of the basal ganglia, derived 
from fine grain neuroanatomical and physiological analysis, fuelled speculation 
on the potential role of the basal ganglia in functions other than motor 
processing, including learning, memory and motivated behaviour. 
 In addition to the anatomical analysis of the basal ganglia circuitry, 
pioneering experimental studies on the phenomenology of human basal ganglia 
pathology and behavioural evidence accrued in experimental animals has 
documented a wide implication for the basal ganglia in adaptive non-motor 
behaviour. Studies in animals with lesions to the striatum (neostriatum in the 
rat and caudate and putamen nuclei in nonhuman primates) demonstrated 
impairments in non-motor tasks including alternation performance, resistance 
to extinction and conditioned avoidance [e.g. 8,9,10,11,12,13]. Since those 
first studies, experimental evidence has been gathered from a variety of 
sources including among others electrophysiological recordings, lesion and 
inactivation studies, and neuropsychological and neuroimaging data supporting 
the basal ganglia as a key substrate for implicit memory function, a cognitive 
adaptation different but not totally alien from the memory systems residing in 
the medial temporal lobe.  
 Drug addiction is a multi-faceted process that involves the acquisition of drug-
seeking and drug-taking behaviours, their maintenance, and their eventual 
extinction and reinstatement. Drug addiction is a disease of the brain characterized 
by difficulties in limiting drug intake, patterned and sequential compulsive 
behaviours including recurring thoughts and actions, strong resistance to extinction 
in the face of declarative knowledge of the adverse consequences for the addict’s 
own health, and relapse. Drugs are notorious for their ability to modify the activity 
of dopamine-modulated systems implicated in learning and memory function. We 
propose in the following account that drug addiction is a special case of 
maladaptive learning mediated by the basal ganglia and we will review 
experimental evidence in animals and humans to support this hypothesis. 
 
Overview of the neuroanatomy of the neostriatum and 
allied thalamocortical pathways 
General anatomical considerations 
 The concept of basal ganglia refers to a number of intimately interrelated 
subcortical structures, including the striatum, the pallidum, the subthalamic 
nucleus and the midbrain dopamine (DA) system as main components. The 
chief input structure of the basal ganglia is the striatum, which receives 
massive projections from the entire cortical mantle and from monoaminergic 
neurotransmitter systems in the midbrain. 
 First, representing the input stage of the system, the striatum displays a 
complex modular ordering of afferent/efferent projections and neurochemical 
Juan J. Canales et al. 56
systems, reflected in a multilevel functional organisation [14,15]. The first 
organisational level is determined by the pattern of striatal dopaminergic 
projections that originate in the mesencephalon. There is at least a crude 
topographical relationship between the area of origin of the dopaminergic 
projection and the region innervated in the striatum. A second level of 
organisation in the striatum is determined by the orderly pattern of termination 
of the corticostriate projections. There is a clear topographical delineation such 
that restricted areas of the cortex project to distinct territories in the striatum. A 
third organisational principle is imposed by the neurochemical compartmental 
organisation of the striatum into patch and matrix compartments. Last, the 
fourth level of functional ordering is determined by the segregation of striatal 
outputs to the substantia nigra/pallidal complex (substantia nigra/entopeduncular 
complex in the rat) and to the external segment of the globus pallidus through 
direct and indirect striatofugal pathways. 
 Two crucial aspects of the organisation of the corticostriate projections is 
that they are somatotopically organised and topographically distributed [16], 
such that there is a point-to-point transfer of information between the cortex 
and the striatum and that specific portions of the cortex project to circumscribed 
striatal zones with relatively little overlap from adjacent, generally 
interconnected cortical areas. The segregated pattern of projection of the 
corticostriate pathways led to a tripartite subdivision of the striatum, namely 
the sensorimotor, the associative and the limbic territories[ 17,18]. The 
sensorimotor territory includes the postcommissural dorsolateral neostriatum 
and receives projections from primary motor and sensorimotor cortices. The 
associative territory comprises large portions of the dorsal neostriatum with 
the exception of its dorsolateral aspect and receives innervation from association 
cortices in the frontal, temporal and parietal lobes. Last, the limbic territory 
includes the nucleus accumbens, the olfactory tubercle, and the most ventral 
and anterior parts of the neostriatum and receives strong input from limbic and 
paralimbic cortices, amygdala and hippocampus. In former subdivisions of the 
striatum, emphasis had already been placed on the classical distinction 
between a ventromedial limbic and dorsolateral non-limbic domain [19,20]. 
Such anatomical observations strongly suggested that different sectors of the 
striatum could be contributing differentially to behaviour, on the one hand, and 
that the functions of the striatum could be more complex than previously 
envisaged, on the other. 
 
The patch-matrix organization 
 The pattern of distribution of neurotransmitters and neuropeptides reflects 
the complexity and heterogeneity of the striatum. Neurons in the striatum are 
segregated into patch and matrix compartments. This patch-matrix 
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organisation was initially demonstrated with µ-opiate receptor binding [21], 
acetylcholinesterase histochemistry [22], and subsequently with other 
neurochemical markers, including those for neurotransmitter systems like 
dopamine, serotonin and GABA, and those for neuropeptides such as enkephalin, 
substance P, somatostatin and dynorphin. The patch-matrix organisation is 
particularly evident in the dorsal striatum. However, the patches and the 
matrix, as they are defined in the dorsal striatum, have not been recognised as a 
distinct feature of the ventral striatum [23]. The patches, or striosomes [22], 
are characterised by more detectable levels of D1 receptors, M1 cholinergic 
receptors, dynorphin and neurotensin, whereas the extrastriosomal matrix is 
richer in dopamine D2 receptor binding and dopamine uptake sites, choline 
uptake sites, acetylcholinesterase, enkephalin and somatostatin [24]. One of the 
most reliable markers of patches and matrix compartments in the neostriatum 
is the labelling of patches with dense opiate-receptor binding. These are 
aligned with patches of weak calcium-binding protein (calbindin-D28kDa) 
immunoreactivity. Conversely, parts of neostriatum with weak naloxone 
binding and strong calbindin immunoreactivity are regarded as matrix. The 
patch-matrix organisation of the striatum is intimately related not only to the 
specific pattern of termination of striatal afferents, but also to the ordering of 
striatal output pathways. Virtually all afferent systems of the striatum adhere to 
the patch-matrix organisation, a rule by which the striatum is able to channel 
these inputs into specific neurochemical environments. Initially, it became 
apparent that prefrontal and limbic cortices display a preference for patches, 
whereas sensorimotor, parietal and occipital cortices show a tendency to 
innervate the matrix compartment. However, the distribution of the inputs from 
cortical areas to the striatum is not strictly categorised into patch and matrix. 
For example, it was shown that corticostriate projections from the frontal 
insular cortex preferentially innervate the patches dorsally and the matrix 
ventrally [25], suggesting a systematic dorso-ventral realignment of cortical 
inputs. Moreover, the distribution of cortical inputs to the striatum was 
subsequently proposed to depend upon the lamina of origin in the cortex such 
that corticostriate neurons in deep, infragranular layers of the cortex projected 
to the patches and those in superficial, supragranular layers innervated the 
matrix compartment [14,15]. Adding considerable complexity, the appreciation 
that some corticostriate projections have a patchy distribution in the matrix led 
to the term “matrisomes” [24], suggesting a modular organisation of the matrix 
compartment itself. The neostriatum also receives extensive input from the 
thalamus. This input mainly originates in the intralaminar and the midline 
nuclei, and from specific relay nuclei, such as the ventral anterior, ventral 
lateral and pulvinar nuclei [see 26]. Thalamostriatal input, as well as 
mesencephalic dopaminergic afferents, conform to the patch-matrix 
organisation of the striatum, such that the patch compartment that receives 
Juan J. Canales et al. 58
input from deep cortical laminae is avoided by midline and intralaminar 
thalamic nuclei and is innervated by the most ventral areas of the substantia 
nigra. On the contrary, the portions of matrix compartment receiving input 
from the superficial layers of the cortex are targeted by intralaminar and 
midline thalamic nuclei and by dopamine cell groups in the ventral tegmental 
area, the retrorubral area and the dorsal substantia nigra. This dissociation 
suggests the presence of different mesostriatal and thalamostriatal neurochemical 
systems in the patch and matrix compartments of the striatum. 
 The functional significance of the patch-matrix organisation of the 
striatum is not completely understood. The clustered, compartmental 
arrangement of neurons in the striatum was conceptualised as a channelling 
mechanism that maintained the segregation of cortical input/output [27,15], 
through basal ganglia-thalamocortical channels. Further, the patch-matrix 
organisation has been related to limbic and non-limbic functions of the 
striatum. The matrix is preferentially innervated by the sensorimotor cortex, 
whereas the patches receive input from areas affiliated with the limbic system, 
such as the amygdala and the prelimbic cortex [24,14]. However, this 
dissociation is not categorical and only reflects the relative weight of cortical 
afferents to either compartment.  
 
Basal ganglia, striatal activity and habit learning 
Functional definitions of goal-directed actions and habits 
 In an attempt to exclude “non-scientific” concepts from the analysis of 
instrumental behaviour, some learning theorists of the 20th century reduced the 
importance of the consequences of the behaviour in driving subsequent 
responding. Within this framework, goal-directed actions were interpreted in 
terms of stimulus-response (S-R) bonds which are simply strengthened or 
weakened by the result of the action (positive reinforcement or punishment) 
[28,29,30]. Thus, according to this interpretation, the delivery of reward 
reinforces the associative connection between the triggering stimulus and the 
response. Such mechanistic two-process models of instrumental conditioning 
were challenged by other conceptions of instrumental conditioning which 
incorporated sophisticated elements such as internal representations and 
intentionality. Such interpretations of instrumental conditioning emphasized 
the control of action by a representation of the outcome as a goal [31,32], and 
not by antecedent stimuli. Within this context, behaviour was said to be goal-
directed if it involved a twin representation of the contingency between action 
and outcome and a representation of the outcome as a goal. The implications of 
such different conceptions in terms of which underlying cognitive processes 
mediate instrumental behaviour are significant. If an animal is given the 
opportunity to self-administer cocaine or morphine by pressing a lever, it will 
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readily do so. Its behaviour is said to be goal-directed because the animal is   
aware of the relationship between the action and the outcome (lever press 
followed by a pleasurable internal state produced by the drug) and because the 
animal wants the outcome to occur. Such response-outcome association 
implies, therefore, declarative, explicit knowledge of the relationship between 
instrumental actions and their consequences. By contrast, the behaviour is said 
to be stimulus-bound if the animal responds on the lever because it has learned 
an association between the lever and the action. Such association gains 
strength through drug reinforcement. In this regard, the behaviour requires no 
explicit knowledge and is simply a reflection of a procedural, mechanical 
course of action. These actions are referred to as habits because subsequent 
changes in the value of the reinforcer (in this case, the drug) generally fail to 
affect responding. 
 
 There is ample evidence to support that animal behaviour is driven by both 
action-outcome and stimulus-response associations. Research over the past 
decades showed that animals encode action-outcome relationships, driving 
their behaviour according to the anticipated consequences of their actions. 
Assays have been developed to manipulate both the value of the reinforcer 
(reinforcer devaluation) and the action-outcome contingency (contingency 
degradation). Such tests allow the decision as to whether behaviour is goal-directed 
or stimulus-driven. For example, drug reinforcement can be devalued by pairing 
drug infusions with shock [33]. Introducing free rewards in a non-contingent 
fashion degrades action-outcome relationships [34,35]. For any given behaviour 
to be considered as goal-directed, it must be affected by reinforcer devaluation 
and contingency degradation. Conversely, the behaviour will be considered a 
habitual form of responding if it does persist under these conditions [36,37].  
 Can we reconcile the two opposing perspectives of instrumental 
conditioning? It has become apparent that two critical factors facilitate the 
acquisition of habits in experimental animals: overtraining and variable 
schedules of reinforcement. Indeed, extended training in instrumental tasks 
promotes stimulus-response bonds and habit formation [38,39]. Similarly, 
interval schedules of reinforcement, but no fixed ratio schedules, facilitate the 
emergence of automatic forms of responding [40], presumably because of the 
weaker response-outcome contingency associated with such schedules. Thus, 
both reiteration and unpredictability could make the progression from action-
outcome strategies to stimulus-response habits possible, both by increasing the 
amenability for association between actions and antecedent stimuli or contexts, 
and by reducing the strength of the association between actions and 
consequences. Goal-directed actions and habits could thus be regarded as 
processes representing stages of the same learning continuum. 
 McDonald and White [41] proposed one of the most influential 
neurobiological accounts of learning and mnemonic function by dissociating 
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three subsystems within the brain. These different memory systems were 
postulated to have nodal points in the hippocampus, the amygdala and the 
neostriatum, and to be responsible for declarative, emotional and procedural 
memory, respectively. According to this and other similar conceptions [e.g. 
42,43] the basal ganglia as a whole, and the neostriatum in particular, were 
regarded as central to the incremental acquisition of stimulus-response 
associations which form the basis of implicit, habit-building knowledge. 
Behavioural data supported the mediation of habit learning by the basal 
ganglia and the relative independence of habit learning from the memory 
functions that sustain the acquisition of hippocampal-based declarative 
knowledge, on the one hand, and of amygdala-based Pavlovian affective 
learning, on the other. Such independence is more hypothetical than real, 
however, as interactions between the subsystems are likely to occur both 
directly at the level of the neostriatum, which receives strong projections from 
the hippocampus and amygdala, and through the complex array of basal 
ganglia loop pathways spanning the telencephalon. 
 
Sensorimotor striatum and the learning of habits 
 Extensive evidence indicates that the neostriatum and affiliated basal 
ganglia structures are necessary for the incremental acquisition of stimulus-
response associations or habits. Behavioural assays combined with lesions of 
the dorsolateral striatum provided strong evidence in favour of this hypothesis. 
Packard et al. [44] studied the behaviour of rats with lesions of the dorsolateral 
striatum using the 8-arm radial arm maze. In the win-shift version of the task, 
rats are required to retrieve food pellets placed in each of the eight arms of the 
maze in a single session carried out daily. Entries into arms previously visited 
within the session are scored as incorrect entries and are thought to represent 
errors of spatial working memory. The win-stay version of the task is 
essentially a visual discrimination task in which only four illuminated arms 
contain food pellets. The rats have to learn the relationship between the 
stimulus (light) and the response (arm entry). The win-stay task is devoid of 
spatial or working memory requirements and probably involves the acquisition 
of a stimulus-response habit. Sage and Knowlton [45] demonstrated that rats 
over trained in the win-stay version of the task continued to enter into the 
illuminated arms even when the food was subsequently devalued by pairing it 
with nauseating injections of lithium chloride. Analogous tasks were 
developed for the Morris water maze in which the location of the platform 
might be visible or might be located under the water. The rats locate the 
platform depending on visual or allocentric cues. The studies showed that the 
mnemonic function of the dorsolateral striatum and the hippocampus could be 
doubly dissociated on these tasks. Lesions of the dorsal striatum impaired the 
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acquisition of stimulus-response habits but not the ability to solve the spatial 
tasks, while lesions of the hippocampus produced the opposite pattern of 
results [44,41]. Further supporting a role for the striatum in habit learning, 
other tasks which probably require the formation of stimulus-response 
associations, including conditional visual [46] and auditory [47] discrimination 
learning and two-way active avoidance [48], were shown to be sensitive to 
lesions of the dorsal sector. 
 In addition to lesion studies, electrophysiological recordings from identified 
striatal neurons during the execution of behavioural tasks suggest the implication 
of the dorsal striatum in habit-based responding. Using multiunit recording and 
tetrode technology in a T-maze auditory discrimination task for food 
reinforcement, Jog et al. [49] demonstrated changes in the activity of neuronal 
ensembles in the dorsolateral striatum during the sensorimotor acquisition of 
stimulus-response learning, such that spike activity only incremented at the 
beginning and the end of the task as learning proceeded. This would be consistent 
with the gradual building of a task-dependent motor set that undergoes 
strengthening through positive reinforcement. Further, Barnes et al. [50] showed 
extensive re-organization of neuronal activity in the sensorimotor striatum during 
acquisition, extinction and re-training of the same procedural T-maze task. 
These observations strongly suggest that plastic and dynamic neuronal activity 
in the dorsolateral striatum is a correlate of habit-based learning. 
 Human data from neurologically affected patients also comes in support 
for the hypothesis that the dorsal striatum mediates the learning of habitual 
forms of responding, of non-motor tendencies and of knowledge in the absence 
of awareness. 
 Explicit memories dependent on the integrity of structures in the medial 
temporal lobe are acquired rapidly, often in the course of one trial or episode, 
and are flexible, for they are remembered consciously and applied readily to 
novel situations. Implicit memories are acquired slowly and gradually, 
generally in the course of many trials, and are stereotyped and rigid, as 
performance collapses when the rules of the task are modified. Such different 
memories are mediated by distinct neural substrates in the human brain 
[51,52]. For example, one of the tasks used to dissociate these abilities in 
humans is the probabilistic task, in which patients are required to guess, based 
on probability, which of two outcomes follows a particular stimulus presented 
in the trial. Stimuli and outcome are probabilistically linked and so it is 
difficult to learn the relationship explicitly. Amnesic patients show normal 
learning of the probabilistic task but show no declarative memory for the 
training episode. In turn, non-demented patients with Parkinson´s disease 
cannot learn the probabilistic task, but do remember the training episode [43]. 
Patients with Tourette´s syndrome also failed in a similar classification task 
involving weather prediction [53]. Moreover, patients with medial temporal 
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lobe dementia were abnormally slow in an object discrimination task in which 
subjects had to choose the reinforced object of a pair and explicitly remember 
the associations. However, they did eventually learn the object-reinforcement 
associations, though without any awareness or declarative knowledge, as 
patients could not describe the task, the objects or the instructions given [54]. 
Such findings were interpreted as evidence for an intact learning system that 
mediates implicit learning and operates independently of the medial temporal 
lobe system. Recent observations in patients with focal neurological damage 
point to the putamen nucleus, the human homolog of the rat dorsolateral striatum, 
as key anatomical substrate for such rule-based, implicit knowledge [55]. 
 
Involvement of nigrostriatal dopamine in habit learning 
 As previously indicated, [56] showed that reinforcer devaluation following 
extensive training under interval schedules for sucrose reinforcement failed to 
affect instrumental responding in control rats, thereby suggesting habit 
formation, whereas responding was reduced by devaluation in rats with lesions 
of the dorsolateral striatum, thus suggesting preserved outcome expectancy in 
these rats. Therefore, instrumental behaviour continues to be under the control 
of the outcome after overtraining in the absence of the dorsolateral striatum. 
Physiological observations indicate that neurons in the dorsal striatum of the 
monkey increase their firing rates in response to reward-related signals after 
overtraining, and that such enhancement is blocked or attenuated by impairing 
dopamine transmission within this region [57]. Is neostriatal dopamine 
essential to habit formation? Faure et al. [58] compared the performance of 
control rats with that of rats with 6-hydroxydopamine lesions of the terminal 
projection to the dorsolateral striatum in tests of goal sensitivity after extended 
training in cued instrumental tasks. Control rats were insensitive to outcome 
devaluation, a fact consistent with the hypothesis that their behaviour had 
become habitual, whereas rats sustaining lesions were sensitive to goal 
devaluation, suggesting that they had been unable to develop a habit. Taken 
together, these findings suggest that nigrostriatal dopamine might play an 
enabling role on habit formation. Most drugs of abuse enhance dopaminergic 
function and produce long-term changes in dopamine-innervated areas. Can we 
therefore establish a relationship between long-term drug-taking, dopamine-
modulated activity in the dorsal striatum, habit formation and drug addiction? 
 
Drug-taking and addiction: Goal-directedness or habit 
Drug addiction and the mesolimbic-accumbens pathways 
 Research over the last two decades has focused on the role of the ventral 
striatum and extended amygdala systems as potential substrates for the 
rewarding and addictive properties of abused drugs. By contrast, the 
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participation of the dorsal striatum has been overlooked, if not disregarded, until 
quite recently. Significant evidence showed that many drugs of abuse, as well 
natural reinforcers such as food, sex and social interactions, enhance dopamine 
neurotransmission in the mesolimbic dopamine system, most notably in the shell 
region of the nucleus accumbens. Such findings fuelled speculation that these 
pathways sub serve the reinforcing effects of addictive drugs and that they could 
play a central role in the shaping of drug addiction. Reinforcing this hypothesis, 
other behaviours, such as the so-called “natural addictions” –the compulsive 
abuse of natural reinforcers–, have been linked to abnormalities in these brain 
regions [59]. Furthermore, several recent publications reported that 
neuroadaptations in the ventral tegmental-nucleus accumbens dopamine axis 
might contribute to the development of stimulant sensitization, the progressively 
incremented psychomotor response evoked by repeated stimulant treatment 
[60,61,62,63]. Drug sensitization is one of the central elements of the theory of 
addiction proposed by Robinson and Berridge [64]. According to these 
researchers, repeated exposure to drugs produces incremented neuroadaptations 
in the mesolimbic system, which lead to enhanced psychomotor stimulation and, 
in parallel, elevated desire to consume the drug. 
 Other current and influential theories of addiction, including the 
hypothesis of dysregulation of reward and allostasis postulated by Koob and 
Le Moal [65], placed the emphasis on alterations of the mesolimbic dopamine 
system and associated striatal circuitry as a fundamental substrate upon which 
drugs of abuse act to induce the persistent behavioural modifications that 
phenotype addiction.   
 The central implication of the dopamine system innervating the ventral 
striatum in the effects of abused drugs is well substantiated at physiological 
and molecular levels. Several recent studies have focused on the influence of 
drugs of abuse on synaptic function, synaptic morphology and plasticity events 
in the ventral tegmental area and nucleus accumbens synapses. For example, 
Ungless et al. [66] reported that a single exposure to cocaine induced long-
term potentiation of dopamine neurons in the ventral tegmental area. Processes 
of synaptic plasticity in the nucleus accumbens and dopaminergic midbrain 
have been shown to be significantly altered by the molecular actions of drugs 
other than cocaine, including amphetamine, opiates, nicotine and marijuana 
[63,67,68,69]. As well as persistent alterations in physiological responsiveness, 
drugs of abuse can induce lasting modifications in signal transduction 
pathways, early-gene response genes and protein synthesis. Psychomotor 
stimulants, opiates and ethanol produce changes in signal transmission in the 
projection areas of the mesolimbic and nigrostriatal dopamine pathways, which 
translate into cascades of biochemical reactions propagating from the 
membrane to the nucleus of the neurons. Such reactions lead to changes in the 
programming and expression of genes and to enduring modifications in cell 
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morphology and function. How stable are these changes? One of the chief 
mechanisms by which biochemical signals influence gene expression is 
through the regulation of transcription factors, proteins that bind specific regulatory 
elements of certain genes, thereby modifying their transcription. Amongst 
these genes, members of Fos/Jun and NGFI-A families of transcription factors 
have been the most studied in the context of drug administration [70-76]. 
Although the expression of these early response genes is rapid and transient 
following acute drug administration, recent studies identified stable and 
persistent gene isoforms. The transcription factor deltaFosB (35-37 kDa), a 
truncated form of the fosB gene, accumulates gradually in the brain in 
response to chronic exposure to psychomotor stimulants [75,77]. Accumulation 
of deltaFosB protein in the nucleus accumbens could induce differential 
sensitivity to addictive drugs. 
 The evidence implicating the mesolimbic dopamine pathway and the 
nucleus accumbens in the induction of drug effects, including psychomotor 
stimulation, reward and reinforcement, is compelling. Thus, it is likely that 
ventral striatal activation is essential at least during the initial stages of drug-
seeking and drug-taking. Activation of nucleus accumbens neurons and 
mesoaccumbens dopamine are both important for reward procurement. 
Accumbens neurons show patterned discharges during operant responding for 
natural reinforcers such as food and water, as well as during training for 
cocaine self-administration, although either process might recruit different sets 
of neurons [78]. Consistently, Phillips et al. [79] reported some important 
findings. These authors showed enhanced subsecond changes in dopamine 
neurotransmission in the nucleus accumbens during key stages of cocaine self-
administration. Increases in extracellular levels of dopamine were observed 
within seconds preceding the reinforced responses for cocaine that coincided 
temporally with the initiation of drug-seeking responses. Changes were also 
noted after response completion. More generally, single-unit recording studies 
demonstrated that dopamine neurons in the midbrain respond phasically to 
novel and unexpected reward, and signal error when predicted reward is 
omitted, thus promoting reinforcement-based learning in expert striatal 
neurons [80,81,82]. Therefore, nucleus accumbens dopamine might play a key 
part in the process of acquiring response-outcome associations that link drug-
seeking, drug procurement and drug-induced reinforcement. 
 
A transition of changes from ventral to dorsal mediates habit 
learning 
 Recent research advances in the neuroscience of drug addiction suggest 
that a progression of changes from ventral-to-dorsal at striatal levels could 
mediate the addiction process. This exciting hypothesis has opened new 
avenues for unravelling the biological processes that promote addictive 
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behaviours. The development of addiction may not simply require the 
establishment of the aforementioned response-outcome associations that so 
firmly depend on the subjective consideration of the drug as a goal. Rather, 
addictive behaviours show remarkable resistance to extinction, even when 
mid-term and long-term consequences for the individual are notoriously 
prejudicial. Loss of control over drug intake, compulsion and relapse are 
central features of addiction. Consequently, the concept of substance addiction 
would harmonize with the notion of gradual consolidation of habit-based 
patterns of responding [83-88], patterns that build slowly through action-
outcome learning and consolidate into stimulus-response learning. This 
hypothesis prompts a critical question. What is the nature of the stimuli that 
trigger drug-seeking in addicts? Are they only conditioned exteroceptive 
stimuli such as drug paraphernalia, locations where the drug was experienced 
or general stimuli classically conditioned to drug experiences? Alternatively, 
are feelings of discomfort, disphoria or depression typically associated with 
withdrawal also important as stimuli precipitating drug-seeking? These 
interoceptive feelings are probably just as significant in provoking drug-
oriented responses and relapse. We have previously proposed that both 
exteroceptive and interoceptive stimuli can form stimulus-response bonds, 
recruiting the loop pathways in the sensorimotor striatum that ground habit-
based knowledge [88]. Is there neurobiological and behavioural evidence to 
support the claim that drug addiction may indeed result from such subversion 
of adaptive memory systems? In other words, are the manifestations of impulse 
control deficits and of relapse after protracted abstinence from drugs the result 
of strengthened stimulus-response processes? 
 
 Several lines of evidence, including anatomical, neurochemical and 
behavioural observations come to support the idea that addiction could involve 
a transition from action-outcome responses to stimulus-bound, habitual 
behaviours and that a key element in such a process resides in the dorsal 
striatum. Haber et al. [89] studied the reciprocal projections between the 
striatum and dopamine cells in the midbrain of the monkey. These authors 
described a spiralling system connecting the shell of the nucleus accumbens 
with dopamine cells that innervated neurons in the core of the nucleus 
accumbens, which, in turn, projected to dopamine cells connecting with the 
dorsal striatum. Such hierarchical system could mediate dopamine-modulated 
transfer of synthesized information from ventral to dorsal structures within the 
striatum. In this fashion, motivational and emotional information processed in 
the extended amygdala systems would find a dopamine-dependent route to 
recruit and consolidate motor programs built and strengthened through 
reinforcement. Behavioral and neurochemical assays with drugs of addiction 
provided hints that such progression might in fact occur. Early-gene assays 
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demonstrated that repeated psychomotor stimulant treatment produced 
network-level adaptations in the dorsal striatum. Canales and Graybiel [76] 
showed that intermittent cocaine or amphetamine administration in rats 
induced lasting modifications in the activation of matrix neurons within the 
dorsal striatum. Repeated exposure to stimulants produced selective activation 
of striosome neurons, dampening the activation of neurons in the matrix. 
Further, the degree to which activation in the striosomes exceeded that in the 
matrix predicted the expression of sensitized motor responses. Such a 
phenomenon is dependent on the concurrent activation of dopamine receptors 
[90] and it is not readily apparent in the compartments of the nucleus 
accumbens [91]. This evidence critically indicated that repeated drug exposure 
re-organizes the activation of dorsal striatal neurons when challenges with the 
drug are experienced subsequently. 
 Models of drug self-administration have provided additional evidence 
pointing at the dorsal striatum as a substrate for habitual responding in the 
context of drug-seeking and drug-taking behaviours. Ito et al. [92] trained rats 
extensively in cocaine self-administration and paired reinforcement with a 
conditioned stimulus (light). These authors showed that the presentation of the 
conditioned stimulus in the absence of cocaine elevated extracellular 
concentrations of dopamine in the dorsal striatum, but not in the nucleus 
accumbens, suggesting that dorsal structures signal the occurrence of events 
that have become tightly linked with drug-seeking behaviours. Interestingly, 
comparing the brains of rhesus monkeys with varying degrees of experience in 
cocaine self-administration, Letchworth et al. [93] showed a progression of 
changes from ventral to dorsal within the striatum. These researchers used 
positron emission tomography to measure dopamine transporters sites at 
different locations and found a gradual accumulation in the sensorimotor 
striatum as training progressed. Critical observations have also been made in 
human addicts using neuroimaging techniques. Abnormal activation patterns 
have been found in the dorsal striatum of drug addicts [94], including a direct 
relationship between aberrant dopamine release in the dorsal striatum and the 
experience of drug craving [95]. Therefore, recent evidence, accumulated over 
the last few years, suggests a potential role for the dorsal striatum in the 
mediation of motor responses, conditioned responses and affective states 
associated with the long-term use of addictive drugs.    
 
Basal ganglia and neurobiology of relapse to drug-
seeking  
 One of the essential characteristics typifying drug addiction is relapse. 
Activation of drug desire by internal and external stimuli holds a central 
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position in the recurring nature of substance use disorders [96-99]. One of the 
most salient features that occurs during withdrawal or abstinence from 
compulsive drug use is the ability of drug-associated environmental cues (e.g. 
drug-associated locations and paraphernalia) and unobservable internal states 
(e.g., disphoria, anxiety) to elicit drug desire. The systematic investigation of 
the impact of conditioned stimuli in experimental animals and of subjective 
craving in drug dependent humans has been performed mainly through studies 
of cue reactivity. Studies of cue reactivity have given rise to a number of 
theoretical models, most of which use the principles of classical conditioning 
to account for cue-elicited craving and reactivity [100-102].  
 Conditioned stimuli can play a key part both in on-going drug-seeking and 
drug-taking and in the triggering of craving and renewed desire for taking the 
drug. In abstinent cocaine addicts the presentation of stimuli previously 
associated with the use of cocaine produced both physiological arousal and 
strong self-reports of craving for the drug [103,104]. Conditioned responses of 
this nature have also been noted for drugs other than cocaine, including alcohol 
[97], opiates [105] and nicotine [106].  
 One of the most reliable and meaningful methods for studying the 
neurobiology of addiction and the mechanisms of relapse is the self-
administration model. Animals such as rodents and monkeys will self-
administer cocaine, alcohol and a variety of other psychoactive compounds if 
given the opportunity to do so [107,108]. This is typically performed in self-
administration chambers where an operant response on a lever activates an 
infusion pump to deliver a measured amount of drug via a catheter implanted 
intravenously. In the case of alcohol self-administration, a number of 
additional methods have been used. The superiority of the self-administration 
method lies in the fact that reinforcement is given a response-contingent 
manner, such that rapid associations between the response and the outcome can 
be made. The self-administration procedures allow to model different aspects 
of the process, including the acquisition of responses, maintenance, extinction 
or abstinence (active or passive extinction) and reinstatement. 
 The vast majority of studies in the last two decades have explored the 
neural substrates underlying the acquisition and maintenance of drug-related 
responses but considerable focus has been aimed more recently at deciphering 
the mechanisms responsible for relapse to drug-seeking after discontinuation 
of drug self-administration. Drug discontinuation is typically done by exposing 
the animal to the context of drug self-administration (e.g., chambers, levers) 
but removing drug availability. As lever presses are no longer reinforced, drug 
responses extinguish. Three methods have been used to reinstate drug-seeking 
behaviour: conditioned cues (e.g., light or sound), priming injections of the 
drug (e.g., an injection of cocaine) and stress (e.g., footshock). All of these 
factors are known to induce craving and renew drug desire in detoxified human 
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subjects [109,110]. Extensive work has been performed over the last decade to 
identify the anatomical pathways and the neurotransmitter systems implicated 
in reinstatement of drug-seeking. Data derived from these studies suggested 
that the molecular events that mediate cue-, drug- and stress-induced 
reinstatement are not identical and that the anatomical circuits implicated are 
only partially overlapping. Several laboratories have characterized the cortico-
basal ganglia loop pathways that mediate the acquisition, maintenance and 
reinstatement of drug-seeking. If we examine the research literature on 
reinstatement of drug-seeking, the nucleus accumbens, the prefrontal cortex 
and the mesolimbic dopamine pathways feature prominently as key common 
elements of the distributed circuitry that mediates relapse to various drugs of 
abuse [110]. Thus, only the ventral domains of the basal ganglia have been 
consistently implicated in relapse. By contrast, the putative role of the dorsal 
striatum in relapse to drug-seeking has been neglected until quite recently. 
 Concerning the potential role of the dorsal striatum and affiliated basal 
ganglia circuits in relapse, critical observations have been recently made by the 
group of Ronald E. See at the South Carolina Medical School. Using local 
inactivation procedures with baclofen and muscimol, this laboratory has shown 
that in rats that undergo forced abstinence in place of explicit extinction 
training, intact function of the dorsolateral striatum is required for robust 
cocaine-seeking at the time of reinstatement [111]. In abstinent rats, 
inactivation of the basolateral amygdala or the dorsolateral prefrontal cortex 
failed to block reinstatement of cocaine seeking. Further, Fuchs et al.[111] 
showed that within the dorsolateral striatum both dopamine D1 receptors and 
glutamate AMPA receptors participate in the reinstatement of drug-seeking 
responses. Interestingly, D1 and AMPA receptors are positively coupled to 
ERK (extracellularly regulated kinase) phosphorylation [112,113], and ERK 
has been postulated as a “coincidence detector” that transduces coordinate 
activation of dopamine and glutamate receptors into changes in gene 
expression [114]. Further, D1 receptors are expressed abundantly by striosome 
projection neurons of the dorsolateral striatum and repeated stimulant exposure 
enhances gene expression in this population of neurons [76]. Thus, the use of 
the abstinence model, which is superior to the active extinction model in terms 
of face validity, may provide new and exciting leads in the participation of the 
dorsal striatum in relapse to drug-seeking. 
 
Concluding remarks and future directions 
 The findings described in the foregoing section come at a time of growing 
interest within the addiction research field on the role of the dorsal striatum 
and allied thalamocortical pathways in habit learning. Compelling data has 
already accumulated from numerous sources pointing at the dorsal striatum as 
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an active participant in drug-induced sensitization, drug conditioning, craving 
and relapse to drug-seeking. Several novel observations in animals and humans 
have confirmed this possibility. In addition, concepts from learning theory, 
including the notions of stimulus-response learning, implicit knowledge and 
habit have been elegantly associated with patterned activity of basal ganglia 
circuits spanning through the dorsal striatum. Considered altogether, these 
novel observations and theoretical approximations constitute to date one the 
most interesting and heuristic corpus of data on the neurobiology of drug 
addiction, and one certainly worth exploring much further. 
 The basal ganglia nuclei are a dynamic set of structures exposed to heavy 
information trafficking, feedback and relay. The parallel nature of the basal 
ganglia circuits makes it essential to identify the anatomical structures that in 
concert with the dorsal striatum mediate the plastic events that lead up to the 
consolidation of drug-seeking behaviours and their reinstatement following 
discontinuation. Also, it will be critical to identify the neurochemical systems 
and transduction pathways responsible for such plasticity of neostriatal 
neurons. In the next few years, we can look forward to unravelling the 
participation of specific sectors of the medial prefrontal cortex, including 
prelimbic, infralimbic and cingulate cortices, in the transit from action-
outcome responses to habit-based responding for drugs of abuse. Similarly, a 
more complete picture will emerge when activity in the basal ganglia 
projection areas of the neostriatum is examined, particularly in the substantia 
nigra and the globus pallidus and, by implication, in the thalamus. Moreover, 
within the dorsal striatum, the intricate patch-matrix organization probably 
hides new treasures to unwrap. Indeed, striosome neurons of the dorsal 
striatum are recipients of inputs from the limbic brain, including input from the 
medial prefrontal cortex and the amygdala, and directly control the firing of 
dopamine neurons in the midbrain. Thus, striosome neurons are centrally 
positioned to regulate the long-term effects of abused drugs. 
 Studies on human basal ganglia pathophysiology have focused for decades 
on the motor disturbances exhibited by patients with Parkinson’s disease, 
Tourette syndrome, Huntington’s chorea and several other neurodegenerative 
conditions affecting the integrity of the basal ganglia. We now know that the 
functions of the basal ganglia are much broader than previously thought. The 
activity of the basal ganglia appears to be necessary for the storage of memories 
that bind actions with consequences, stimuli and with previously reinforced 
actions. Action-outcome and stimulus-action strategies could represent ends of a 
continuum through which practice and iteration of actions promotes adaptive 
automatic performance independent of dedicated neural systems that mediate 
declarative learning. In this context, the basal ganglia could perform the vital 
task of translating reinforced goal-directed actions into invariant stimulus-bound 
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behaviours. One aspect that deserves future attention is to understand specifically 
how goal-directed behaviours become habits, and how these may become 
compulsive. Such understanding may throw new light on the neurobiology of 
addictive disorders and the role of the basal ganglia in adaptive behaviour. 
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